Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

July 2023

HNL Lab Medicine Announces Groundbreaking Digital Pathology Investment

2023-07-18T11:26:28+00:00

HNL Lab Medicine, a leading clinical diagnostics laboratory, is pleased to announce an investment in a new digital pathology initiative. HNL Lab Medicine has selected solutions from Proscia, a digital pathology software company, and Leica Biosystems, a manufacturer of high-quality imaging hardware, to establish an advanced digital pathology practice. This investment will enhance the lab’s diagnostic capabilities, improve efficiency, and ultimately provide better patient care.

HNL Lab Medicine Announces Groundbreaking Digital Pathology Investment2023-07-18T11:26:28+00:00

University of Florida College of Medicine – Jacksonville Adopts Paige’s AI for Enhanced Cancer Diagnosis

2023-07-13T16:04:57+00:00

Paige, a global leader in end-to-end digital pathology solutions and clinical artificial intelligence (AI) applications for diagnosing cancer, and University of Florida College of Medicine – Jacksonville today announced the Department of Pathology and Laboratory Medicine’s decision to adopt Paige’s full portfolio of AI offerings for their lab, including the Paige Prostate Suite and Paige Breast Suite.

University of Florida College of Medicine – Jacksonville Adopts Paige’s AI for Enhanced Cancer Diagnosis2023-07-13T16:04:57+00:00

From Digital Microscopy To Digital Pathology Through Image Analysis. How Far Have We Come In 20 Years? Michael Grunkin, Visiopharm

2025-05-06T12:58:35+00:00

The complexity of digital pathology problems and research questions increases with every additional stain and scientific discovery. Visiopharm’s team challenged themselves by providing an image analysis solution capable of addressing this hypercomplexity and enabling researchers to advance scientifically with their tool.

From Digital Microscopy To Digital Pathology Through Image Analysis. How Far Have We Come In 20 Years? Michael Grunkin, Visiopharm2025-05-06T12:58:35+00:00

New Computational Pathology Tool Predicts Gene Expression Values From Whole Slide Images of Biopsies

2025-06-26T15:54:52+00:00

For many diseases, molecular testing may provide rich information for both diagnosis and treatment planning. Combining or aggregating tissue morphology information with molecular data may improve the accuracy of patient matching. Nonetheless, molecular analyses, such as RNA sequencing, are expensive and time-consuming and may require additional tissue samples. Predicting gene expression values from whole slide images (WSIs) is limited by weakly supervised challenges due to the lack of pixel-level annotations for each tile in the WSI. On the other hand, searching for similar anatomic clues has been demonstrated to be a powerful unsupervised technology.

New Computational Pathology Tool Predicts Gene Expression Values From Whole Slide Images of Biopsies2025-06-26T15:54:52+00:00

The Role of Digital Pathology in Cancer Diagnostics within the NHS Operational Planning Guidance Plan

2023-07-12T10:46:20+00:00

The NHS (National Health Service) in England has always aimed to be at the forefront of implementing innovative technologies to advance patient care. The 2023/24 operational planning guidance plan demonstrates this commitment by outlining the key role of digital pathology and imaging networks in enhancing cancer diagnostics and improving overall healthcare outcomes.

The Role of Digital Pathology in Cancer Diagnostics within the NHS Operational Planning Guidance Plan2023-07-12T10:46:20+00:00

How Tissue Clearing – Based 3D Immunofluorescence Allows For Seeing More Biology In The Tissue With/ Sharla White, Clearlight Biotechnologies

2025-05-06T13:00:13+00:00

Even though tissues are tridimensional structures, most tissue research is done on two-dimensional tissue slides. This leaves a tremendous amount of biological information on the table. This episodes’ guest – Sharla White, Ph.D., the vice president of research and development at ClearLight Biotechnologies explains how tissue clearing and 3D immunofluorescence can take your tissue research to a whole new level.

How Tissue Clearing – Based 3D Immunofluorescence Allows For Seeing More Biology In The Tissue With/ Sharla White, Clearlight Biotechnologies2025-05-06T13:00:13+00:00

Case Of The Month | July 2023 | Malasezzia spp. Organisms Within Keratin Of The Haired Skin Of A 2-month-old Seal Pup

2023-07-02T22:03:17+00:00

Digital sections showing abundant, spherical, 2-5um diameter, PAS positive (special stain) structures consistent with Malasezzia spp in skin biopsies from a 2-month-old seal pup that had developed generalised alopecia that

Case Of The Month | July 2023 | Malasezzia spp. Organisms Within Keratin Of The Haired Skin Of A 2-month-old Seal Pup2023-07-02T22:03:17+00:00

June 2023

Activated Erk 1/2 Kinases Decrease Cell Viability Caused by Erastin in HNSCC

2023-06-28T07:46:15+00:00

Head and neck cancers originating from the mucosal epithelium in the oral cavity, larynx, and pharynx are collectively referred to as neck and head squamous cell carcinoma (HNSCC). As one of the sixth most common cancers worldwide

Activated Erk 1/2 Kinases Decrease Cell Viability Caused by Erastin in HNSCC2023-06-28T07:46:15+00:00

Indica Labs Is Named a Top Workplace by the Albuquerque Journal for the Fourth Year Running

2023-06-27T09:59:24+00:00

Indica Labs, a leading provider of computational pathology software, is delighted to announce that they have been awarded a Top Workplaces™ honor by The Albuquerque Journal for the fourth year in a row.

Indica Labs Is Named a Top Workplace by the Albuquerque Journal for the Fourth Year Running2023-06-27T09:59:24+00:00

Diagnexia Expands Pathology Services with State-of-the-Art Accessioning Facility in Toronto, Revolutionising Digital Pathology and Enhancing Patient Care

2023-06-23T17:34:06+00:00

Diagnexia Canada Limited, owned by Deciphex Limited and internationally recognized as a leading provider of pathology services, is delighted to announce the launch of its cutting-edge accessioning facility in Toronto. 

Diagnexia Expands Pathology Services with State-of-the-Art Accessioning Facility in Toronto, Revolutionising Digital Pathology and Enhancing Patient Care2023-06-23T17:34:06+00:00
Go to Top